| Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches T Karantanos, PG Corn, TC Thompson Oncogene 32 (49), 5501-5511, 2013 | 864 | 2013 |
| Fecal Colonization With Extended-spectrum Beta-lactamase–Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review … S Karanika, T Karantanos, M Arvanitis, C Grigoras, E Mylonakis Reviews of Infectious Diseases 63 (3), 310-318, 2016 | 485 | 2016 |
| Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level T Karantanos, CP Evans, B Tombal, TC Thompson, R Montironi, ... European urology 67 (3), 470-479, 2015 | 318 | 2015 |
| Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer L Li, S Karanika, G Yang, J Wang, S Park, BM Broom, GC Manyam, W Wu, ... Science signaling 10 (480), eaam7479, 2017 | 271 | 2017 |
| Immunotherapy comes of age: immune aging & checkpoint inhibitors R Elias, T Karantanos, E Sira, KL Hartshorn Journal of geriatric oncology 8 (3), 229-235, 2017 | 125 | 2017 |
| Current insights in to the pathophysiology of irritable bowel syndrome T Karantanos, T Markoutsaki, M Gazouli, NP Anagnou, DG Karamanolis Gut Pathogens 2, 1-8, 2010 | 117 | 2010 |
| DNA damage response and prostate cancer: defects, regulation and therapeutic implications S Karanika, T Karantanos, L Li, PG Corn, TC Thompson Oncogene 34 (22), 2815-2822, 2015 | 113 | 2015 |
| Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development GE Theodoropoulos, V Saridakis, T Karantanos, NV Michalopoulos, ... The Breast 21 (4), 534-538, 2012 | 106 | 2012 |
| Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity LM Rooper, T Karantanos, Y Ning, JA Bishop, SW Gordon, H Kang The American journal of surgical pathology 42 (8), 1121-1126, 2018 | 100 | 2018 |
| Regulation of T cell differentiation and function by EZH2 T Karantanos, A Christofides, K Bardhan, L Li, VA Boussiotis Frontiers in immunology 7, 190789, 2016 | 88 | 2016 |
| Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-Chk1 signaling S Karanika, T Karantanos, L Li, J Wang, S Park, G Yang, X Zuo, JH Song, ... Cell reports 18 (8), 1970-1981, 2017 | 82 | 2017 |
| Targeting poly (ADP-ribose) polymerase and the c-myb–regulated DNA damage response pathway in castration-resistant prostate cancer L Li, W Chang, G Yang, C Ren, S Park, T Karantanos, S Karanika, J Wang, ... Science signaling 7 (326), ra47-ra47, 2014 | 81 | 2014 |
| Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection GE Theodoropoulos, NA Memos, K Peitsidou, T Karantanos, ... Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of …, 2016 | 71 | 2016 |
| Clock genes: their role in colorectal cancer T Karantanos, G Theodoropoulos, D Pektasides, M Gazouli World Journal of Gastroenterology: WJG 20 (8), 1986, 2014 | 71 | 2014 |
| The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study T Karantanos, S Karanika, B Seth, G Gignac Clinical and Translational Oncology 21, 206-212, 2019 | 69 | 2019 |
| Do anastomotic leaks impair postoperative health-related quality of life after rectal cancer surgery? A case-matched study A Marinatou, GE Theodoropoulos, S Karanika, T Karantanos, ... Diseases of the colon & rectum 57 (2), 158-166, 2014 | 63 | 2014 |
| Immune response after laparoscopic colectomy for cancer: a review S Karanika, T Karantanos, GE Theodoropoulos Gastroenterology report 1 (2), 85-94, 2013 | 60 | 2013 |
| Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2 A Christofides, T Karantanos, K Bardhan, VA Boussiotis Oncotarget 7 (51), 85624, 2016 | 58 | 2016 |
| Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients GE Theodoropoulos, IG Papanikolaou, T Karantanos, G Zografos Techniques in coloproctology 17, 525-536, 2013 | 51 | 2013 |
| Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden T Karantanos, S Chaturvedi, EM Braunstein, J Spivak, L Resar, ... Blood advances 4 (12), 2567-2576, 2020 | 45 | 2020 |
